Fibrin microthreads

Patent metadata

Field	Value
Publication number	US-9662415-B2
Application number	US-201514795537-A
Country	US
Kind code	B2
Filing date	Jul 9, 2015
Priority date	Mar 20, 2006
Publication date	May 30, 2017
Grant date	May 30, 2017

Abstract

Compositions that include fibrin microthreads are provided. The compositions can include one or more therapeutic agents including cytokines and interleukins, extracellular matrix proteins and/or biologically active fragments thereof (e.g., RGD-containing peptides), hormones, vitamins, nucleic acids, chemotherapeutics, antibiotics, and cells. Also provided are methods of making compositions that include fibrin microthreads. Also provided are methods for using the compositions to repair or ameliorate damaged or defective organs or tissues.

First claim

What is claimed is:

1. A method of repairing skin, comprising suturing skin in need of repair with a fibrin microthread to cause skin repair, wherein the fibrin microthread is formed by a process comprising the steps of:
combining a first volume of fibrinogen and a second volume of a molecule capable of forming fibrin from the fibrinogen to form a mixture;
transferring the mixture to a lumen containing device;
disposing a distal end of the lumen containing device in an aqueous bath;
moving the distal end of the lumen containing device through the aqueous bath while extruding the mixture from the distal end of the lumen containing device into the aqueous bath; and
incubating the mixture in the aqueous bath for a predetermined incubation time to form the fibrin microthread.

2. The method of claim 1 , wherein the skin in need of repair comprises a traumatic injury, a congenital malformation, a malfunction, or malformation resulting from an infection, or malformation resulting from a surgical procedure.

3. The method of claim 1 , wherein the skin repair is skin augmentation.

4. The method of claim 1 , wherein the skin repair is skin grafting.

5. The method of claim 1 , wherein the fibrinogen is human fibrinogen or fibrinogen of a non-human primate, a domesticated animal, or a rodent generated either naturally or through recombinant or synthetic protein production techniques.

6. The method of claim 1 , wherein the molecule capable of forming fibrin is a protease.

7. The method of claim 6 , wherein the protease is thrombin.

Assignees

• Worcester Polytech Inst

Inventors

• Cornwell Kevin G
• Pins George D
• Billiar Kristen

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61L2430/34

  for soft tissue reconstruction · CPC title

• A61L2400/04

  Materials for stopping bleeding · CPC title

• A61L2300/252

  Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines · CPC title

• A61P17/02

  for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title